Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2024-07-01 00:00:00 ET · period of report 2024-06-27 · accession 0001415889-24-018515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-01 | 2024-06-27 | TSHA | Manning Paul B | 10% | P - Purchase | $2.25 | +1.33M | 1.33M | New | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-27 | P | A | 1,333,333 | $2.25 | 1,333,333 | D | — | — |